Lucas Venture Group — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Allermiallermi.cominMar 2023 · $3.5M
Allermi offers custom prescription nasal sprays combining up to four active ingredients to treat nasal allergies (rhinitis), delivered via online allergist consultations and home delivery.
Digital HealthDirect to ConsumerHealthtech
Shuba Iyengar(Founder)in
Co-investorsEvolution VC PartnersNelstone VenturesOrigin Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.